CWM
IBB icon

Castle Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Castle Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-470
Closed -$55K – 338
2022
Q3 		$55K Hold
470
– – 0.03% 201
2022
Q2 		$55K Buy
+470
New +$55.8K 0.03% 201

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CANY
Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Castle Wealth Management's IBB Position: Q4 2022 in Review

Castle Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 470 shares — an estimated $55K sold.

Castle Wealth Management first reported a position in IBB in Q2 2022 and held it in 2 quarters. The position peaked at $55K in Q3 2022. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

  • Castle Wealth Management reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
  • Castle Wealth Management sold 470 iShares Biotechnology ETF shares in Q4 2022, an estimated $55K.
  • Castle Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2022 and held it in 2 quarters.
  • Castle Wealth Management's iShares Biotechnology ETF position peaked at $55K in Q3 2022.
  • 902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Castle Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.